COVID-19 vaccine boosters could mean billions for drugmakers

0 6
Check out what's clicking on FoxBusiness.com. Billions more in profits are at stake for some vaccine makers as the U.S. moves toward dispensing COVID-19 booster shots to shore up Americans' protection against the virus. How much the manufacturers stand to gain depends on how big the rollout proves to be.Exactly who should get a booster was a contentious decision as advisers to the Centers for Disease Control and Prevention spent two days this week poring over the evidence. CDC director Dr. Rochelle Walensky endorsed most of their choices: People 65 and older, nursing home residents and those ages 50 to 64 who have chronic health problems such as diabetes should be offered one once they’re six months past their last Pfizer dose. Those 18 and older with health problems can decide for themselves if they want a booster.Stocks in this Article In this March 2021 photo provided by Pfizer, a technician works on a line for packaging preparation for the Pfizer-BioNTec
Subscribe or log in to read the rest of this content.
Leave A Reply

Your email address will not be published.

At The Centre of Every Trade
$59.95/month